Rockville cell therapy manufacturing facility
AstraZeneca, Rockville, Montgomery County, Maryland
Rockville cell therapy manufacturing facility in Rockville, Maryland is AstraZeneca’s plant for cell therapies (initially CAR-T for clinical trials). Status: operating (reported) as of May 2025 (opened, reported by news and not yet confirmed by the company or state). AstraZeneca announced $300 million and 150 jobs. Primary source: commerce.maryland.gov, checked November 1, 2026.
- Status
- Operating (reported)
- Announced investment
- $300 million
- Announced jobs
- 150
- Industry
- Pharmaceuticals
- Sheet
- MD-04
- Revised
- November 1, 2026
Status timeline
- Announcedcommerce.maryland.gov
- Opened (reported)tradelineinc.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | AstraZeneca |
|---|---|
| Plant | Rockville cell therapy manufacturing facility |
| Location | Rockville, Montgomery County, Maryland |
| Industry | Pharmaceuticals |
| Product | Cell therapies (initially CAR-T for clinical trials) |
| Announced investment | $300 million |
| Announced jobs | 150 |
| Last checked | November 1, 2026 |
Sources
- Maryland Commerce: AstraZeneca $300M Rockville facility (state release, commerce.maryland.gov, checked November 1, 2026)
- Tradeline: AstraZeneca opens Rockville cell therapy facility (news report, tradelineinc.com, checked November 1, 2026)
Something changed? Send a correction with a link and we'll recheck it.